{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:48:37Z","timestamp":1780055317912,"version":"3.54.0"},"reference-count":71,"publisher":"The Society for Free Radical Research Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2021]]},"DOI":"10.3164\/jcbn.20-103","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T22:05:51Z","timestamp":1602540351000},"page":"37-50","source":"Crossref","is-referenced-by-count":20,"title":["Dietary intake of walnut prevented &lt;i&gt;Helicobacter pylori&lt;\/i&gt;-associated gastric cancer through rejuvenation of chronic atrophic gastritis"],"prefix":"10.3164","volume":"68","author":[{"given":"Jong Min","family":"Park","sequence":"first","affiliation":[{"name":"Daejeon University School of Oriental Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Han","sequence":"additional","affiliation":[{"name":"Western Seoul Center, Korea Basic Science Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Jin","family":"Park","sequence":"additional","affiliation":[{"name":"GI Medics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Baik","family":"Hahm","sequence":"additional","affiliation":[{"name":"CHA Cancer Preventive Research Center, CHA Bio Complex, CHA University"},{"name":"Medpactor Research Institute, Medpacto"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. <i>Helicobacter pylori<\/i> in human health and disease: mechanisms for local gastric and systemic effects. World J Gastroenterol 2018; 24: 3071\u20133089.","DOI":"10.3748\/wjg.v24.i28.3071"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Gonzalez CA, Riboli E. Diet and cancer prevention: where we are, where we are going. Nutr Cancer 2006; 56: 225\u2013231.","DOI":"10.1207\/s15327914nc5602_14"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Ribera-Fonseca A, Jim\u00e9nez D, Leal P, et al. The anti-proliferative and anti-invasive effect of leaf extracts of blueberry plants treated with methyl jasmonate on human gastric cancer <i>in vitro<\/i> is related to their antioxidant properties. Antioxidants (Basel) 2020; 9: 45.","DOI":"10.3390\/antiox9010045"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Al-Ishaq RK, Overy AJ, B\u00fcsselberg D. Phytochemicals and gastrointestinal cancer: cellular mechanisms and effects to change cancer progression. Biomolecules 2020; 10: 105.","DOI":"10.3390\/biom10010105"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Spagnuolo C, Russo GL, Orhan IE, et al. Genistein and cancer: current status, challenges, and future directions. Adv Nutr 2015; 6: 408\u2013419.","DOI":"10.3945\/an.114.008052"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Park Y, Lee H, Lim JW, Kim H. Inhibitory effect of \u03b2-carotene on <i>Helicobacter pylori<\/i>-induced TRAF expression and hyper-proliferation in gastric epithelial cells. Antioxidants (Basel) 2019; 8: 637.","DOI":"10.3390\/antiox8120637"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kim SH, Lim JW, Kim H. Astaxanthin inhibits mitochondrial dysfunction and interleukin-8 expression in <i>Helicobacter pylori<\/i>-infected gastric epithelial cells. Nutrients 2018; 10: 1320.","DOI":"10.3390\/nu10091320"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Park JM, An JM, Han YM, et al. Walnut polyphenol extracts inhibit <i>Helicobacter pylori<\/i>-induced STAT3<sup>Tyr705<\/sup> phosphorylation through activation of PPAR-\u03b3 and SOCS1 induction. J Clin Biochem Nutr 2020; 67: 248\u2013256.","DOI":"10.3164\/jcbn.20-89"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Han YM, Kim KJ, Jeong M, et al. Suppressed <i>Helicobacter pylori<\/i>-associated gastric tumorigenesis in Fat-1 transgenic mice producing endogenous omega-3 polyunsaturated fatty acids. Oncotarget 2016; 7: 66606\u201366622.","DOI":"10.18632\/oncotarget.11261"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gaddy JA, Radin JN, Loh JT, et al. High dietary salt intake exacerbates <i>Helicobacter pylori<\/i>-induced gastric carcinogenesis. Infect Immun 2013; 81: 2258\u20132267.","DOI":"10.1128\/IAI.01271-12"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM. Walnut polyphenolics inhibit <i>in vitro<\/i> human plasma and LDL oxidation. J Nutr 2001; 131: 2837\u20132842.","DOI":"10.1093\/jn\/131.11.2837"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Nam SY, Kim N, Lee CS, et al. Gastric mucosal protection via enhancement of MUC5AC and MUC6 by geranylgeranylacetone. Dig Dis Sci 2005; 50: 2110\u20132120.","DOI":"10.1007\/s10620-005-3016-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Lacy ER, Ito S. Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology 1982; 83: 619\u2013625.","DOI":"10.1016\/S0016-5085(82)80198-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Mera RM, Bravo LE, Camargo MC, et al. Dynamics of <i>Helicobacter pylori<\/i> infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut 2018; 67: 1239\u20131246.","DOI":"10.1136\/gutjnl-2016-311685"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Piazuelo MB, Correa P. Gastric c\u00e1ncer: overview. Colomb Med (Cali) 2013; 44: 192\u2013201.","DOI":"10.25100\/cm.v44i3.1263"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Choi IJ, Kook MC, Kim YI, et al. <i>Helicobacter pylori<\/i> therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018; 378: 1085\u20131095.","DOI":"10.1056\/NEJMoa1708423"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Choi IJ, Kim CG, Lee JY, et al. Family history of gastric cancer and <i>Helicobacter pylori<\/i> treatment. N Engl J Med 2020; 382: 427\u2013436.","DOI":"10.1056\/NEJMoa1909666"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Nagashima H, Yamaoka Y. Importance of toll-like receptors in pro-inflammatory and anti-inflammatory responses by <i>Helicobacter pylori<\/i> infection. Curr Top Microbiol Immunol 2019; 421: 139\u2013158.","DOI":"10.1007\/978-3-030-15138-6_6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Han HS, Lee SY, Oh SY, Moon HW, Cho H, Kim JH. Correlations of the gastric and duodenal microbiota with histological, endoscopic, and symptomatic gastritis. J Clin Med 2019; 8: 312.","DOI":"10.3390\/jcm8030312"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hu YL, Pang W, Huang Y, Zhang Y, Zhang CJ. The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics. Front Cell Infect Microbiol 2018; 8: 433.","DOI":"10.3389\/fcimb.2018.00433"},{"key":"21","unstructured":"21 Han YM, Park JM, Jeong M, et al. Dietary, non-microbial intervention to prevent <i>Helicobacter pylori<\/i>-associated gastric diseases. Ann Transl Med 2015; 3: 122."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Park SH, Kangwan N, Park JM, Kim EH, Hahm KB. Non-microbial approach for <i>Helicobacter pylori<\/i> as faster track to prevent gastric cancer than simple eradication. World J Gastroenterol 2013; 19: 8986\u20138995.","DOI":"10.3748\/wjg.v19.i47.8986"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Lee JS, Paek NS, Kwon OS, Hahm KB. Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in <i>Helicobacter pylori<\/i> infection: a novel mechanism. J Gastroenterol Hepatol 2010; 25: 194\u2013202.","DOI":"10.1111\/j.1440-1746.2009.06127.x"},{"key":"24","unstructured":"24 An JM, Kang EA, Han YM, et al. Dietary threonine prevented stress-related mucosal diseases in rats. J Physiol Pharmacol 2019; 70. DOI: 10.26402\/jpp.2019.3.14"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Lee HJ, Han YM, An JM, et al. Role of omega-3 polyunsaturated fatty acids in preventing gastrointestinal cancers: current status and future perspectives. Expert Rev Anticancer Ther 2018; 18: 1189\u20131203.","DOI":"10.1080\/14737140.2018.1524299"},{"key":"26","unstructured":"26 Park JM, Jeong M, Kim EH, Han YM, Kwon SH, Hahm KB. Omega-3 polyunsaturated fatty acids intake to regulate <i>Helicobacter pylori<\/i>-associated gastric diseases as nonantimicrobial dietary approach. Biomed Res Int 2015; 2015: 712363."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Jeong M, Park JM, Han YM, et al. Dietary prevention of <i>Helicobacter pylori<\/i>-associated gastric cancer with kimchi. Oncotarget 2015; 6: 29513\u201329526.","DOI":"10.18632\/oncotarget.4897"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Jeong M, Park JM, Han YM, et al. Dietary intervention of artemisia and green tea extracts to rejuvenate <i>Helicobacter pylori<\/i>-associated chronic atrophic gastritis and to prevent tumorigenesis. Helicobacter 2016; 21: 40\u201359.","DOI":"10.1111\/hel.12229"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Stewart OA, Wu F, Chen Y. The role of gastric microbiota in gastric cancer. Gut Microbes 2020; 11: 1220\u20131230.","DOI":"10.1080\/19490976.2020.1762520"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Zhao Y, Zhang J, Cheng ASL, Yu J, To KF, Kang W. Gastric cancer: genome damaged by bugs. Oncogene 2020; 39: 3427\u20133442.","DOI":"10.1038\/s41388-020-1241-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Petryszyn P, Chapelle N, Matysiak-Budnik T. Gastric cancer: Where are we heading? Dig Dis 2020; 38: 280\u2013285.","DOI":"10.1159\/000506509"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Eid R, Moss SF. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 2002; 346: 65\u201367.","DOI":"10.1056\/NEJM200201033460115"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Zullo A, Hassan C, Morini S. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 2002; 346: 65\u201367.","DOI":"10.1056\/NEJM200201033460115"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Ishii Y, Shibata W, Sugimori M, et al. Activation of signal transduction and activator of transcription 3 signaling contributes to <i>Helicobacter<\/i>-associated gastric epithelial proliferation and inflammation. Gastroenterol Res Pract 2018; 2018: 9050715.","DOI":"10.1155\/2018\/9050715"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Cao S, Zhu C, Feng J, et al. <i>Helicobacter<\/i> hepaticus infection induces chronic hepatitis and fibrosis in male BALB\/c mice via the activation of NF-kappaB, Stat3, and MAPK signaling pathways. Helicobacter 2020; 25: e12677.","DOI":"10.1111\/hel.12677"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Piao JY, Lee HG, Kim SJ, et al. <i>Helicobacter pylori<\/i> activates IL-6-STAT3 signaling in human gastric cancer cells: potential roles for reactive oxygen species. Helicobacter 2016; 21: 405\u2013416.","DOI":"10.1111\/hel.12298"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Howlett M, Menheniott TR, Judd LM, Giraud AS. Cytokine signalling via gp130 in gastric cancer. Biochim Biophys Acta 2009; 1793: 1623\u20131633.","DOI":"10.1016\/j.bbamcr.2009.07.009"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Bronte-Tinkew DM, Terebiznik M, Franco A, et al. <i>Helicobacter pylori<\/i> cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway <i>in vitro<\/i> and <i>in vivo<\/i>. Cancer Res 2009; 69: 632\u2013639.","DOI":"10.1158\/0008-5472.CAN-08-1191"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Paik JY, Lee HG, Piao JY, et al. <i>Helicobacter pylori<\/i> infection promotes autophagy through Nrf2-mediated heme oxygenase upregulation in human gastric cancer cells. Biochem Pharmacol 2019; 162: 89\u201397.","DOI":"10.1016\/j.bcp.2019.02.003"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Gobert AP, Verriere T, Asim M, et al. Heme oxygenase-1 dysregulates macrophage polarization and the immune response to <i>Helicobacter pylori<\/i>. J Immunol 2014; 193: 3013\u20133022.","DOI":"10.4049\/jimmunol.1401075"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Gobert AP, Asim M, Piazuelo MB, et al. Disruption of nitric oxide signaling by <i>Helicobacter pylori<\/i> results in enhanced inflammation by inhibition of heme oxygenase-1. J Immunol 2011; 187: 5370\u20135379.","DOI":"10.4049\/jimmunol.1102111"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Gobert AP, Verriere T, de Sablet T, Peek RM, Jr, Chaturvedi R, Wilson KT. Haem oxygenase-1 inhibits phosphorylation of the <i>Helicobacter pylori<\/i> oncoprotein CagA in gastric epithelial cells. Cell Microbiol 2013; 15: 145\u2013156.","DOI":"10.1111\/cmi.12039"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Sasaki Y, Nakatani Y, Hara S. Role of microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E2 in colon carcinogenesis. Prostaglandins Other Lipid Mediat 2015; 121 (Pt A): 42\u201345.","DOI":"10.1016\/j.prostaglandins.2015.06.006"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Yang DH, Ryu YM, Lee SM, et al. 15-Hydroxyprostaglandin dehydrogenase as a marker in colon carcinogenesis: analysis of the prostaglandin pathway in human colonic tissue. Intest Res 2017; 15: 75\u201382.","DOI":"10.5217\/ir.2017.15.1.75"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Pham H, Chen M, Li A, et al. Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors. Pancreas 2010; 39: 332\u2013339.","DOI":"10.1097\/MPA.0b013e3181baecbe"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Dai L, King DW, Perera DS, Lubowski DZ, Burcher E, Liu L. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease. Dig Dis Sci 2015; 60: 1236\u20131246.","DOI":"10.1007\/s10620-014-3478-7"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 2012; 188: 21\u201328.","DOI":"10.4049\/jimmunol.1101029"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Tai HH. Prostaglandin catabolic enzymes as tumor suppressors. Cancer Metastasis Rev 2011; 30: 409\u2013417.","DOI":"10.1007\/s10555-011-9314-z"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Cha B, Lim JW, Kim H. Jak1\/Stat3 is an upstream signaling of NF-\u03baB activation in <i>Helicobacter pylori<\/i>-induced IL-8 production in gastric epithelial AGS cells. Yonsei Med J 2015; 56: 862\u2013866.","DOI":"10.3349\/ymj.2015.56.3.862"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Gobert AP, Wilson KT. Polyamine- and NADPH-dependent generation of ROS during <i>Helicobacter pylori<\/i> infection: a blessing in disguise. Free Radic Biol Med 2017; 105: 16\u201327.","DOI":"10.1016\/j.freeradbiomed.2016.09.024"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Jackson CB, Judd LM, Menheniott TR, et al. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 2007; 213: 140\u2013151.","DOI":"10.1002\/path.2218"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Xiong H, Du W, Sun TT, et al. A positive feedback loop between STAT3 and cyclooxygenase-2 gene may contribute to <i>Helicobacter pylori<\/i>-associated human gastric tumorigenesis. Int J Cancer 2014; 134: 2030\u20132040.","DOI":"10.1002\/ijc.28539"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Menheniott TR, Judd LM, Giraud AS. STAT3: a critical component in the response to <i>Helicobacter pylori<\/i> infection. Cell Microbiol 2015; 17: 1570\u20131582.","DOI":"10.1111\/cmi.12518"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Rizzuti D, Ang M, Sokollik C, et al. <i>Helicobacter pylori<\/i> inhibits dendritic cell maturation via interleukin-10-mediated activation of the signal transducer and activator of transcription 3 pathway. J Innate Immun 2015; 7: 199\u2013211.","DOI":"10.1159\/000368232"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Lee KS, Kalantzis A, Jackson CB, et al. <i>Helicobacter pylori<\/i> CagA triggers expression of the bactericidal lectin REG3\u03b3 via gastric STAT3 activation. PLoS One 2012; 7: e30786.","DOI":"10.1371\/journal.pone.0030786"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Kaebisch R, Mej\u00edas-Luque R, Prinz C, Gerhard M. <i>Helicobacter pylori<\/i> cytotoxin-associated gene A impairs human dendritic cell maturation and function through IL-10-mediated activation of STAT3. J Immunol 2014; 192: 316\u2013323.","DOI":"10.4049\/jimmunol.1302476"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Zhao J, Dong Y, Kang W, et al. <i>Helicobacter pylori<\/i>-induced STAT3 activation and signalling network in gastric cancer. Oncoscience 2014; 1: 468\u2013475.","DOI":"10.18632\/oncoscience.62"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Sun TT, Tang JY, Du W, et al. Bidirectional regulation between TMEFF2 and STAT3 may contribute to <i>Helicobacter pylori<\/i>-associated gastric carcinogenesis. Int J Cancer 2015; 136: 1053\u20131064.","DOI":"10.1002\/ijc.29061"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Giraud AS, Menheniott TR, Judd LM. Targeting STAT3 in gastric cancer. Expert Opin Ther Targets 2012; 16: 889\u2013901.","DOI":"10.1517\/14728222.2012.709238"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Nakanishi M, Matz A, Klemashevich C, Rosenberg DW. Dietary walnut supplementation alters mucosal metabolite profiles during DSS-induced colonic ulceration. Nutrients 2019; 11: 1118.","DOI":"10.3390\/nu11051118"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Liu H, Wan Y, Wang Y, et al. Walnut polyphenol extract protects against fenitrothion-induced immunotoxicity in murine splenic lymphocytes. Nutrients 2018; 10: 1838.","DOI":"10.3390\/nu10121838"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Zhao Y, Fan C, Zhang A, et al. Walnut polyphenol extract protects against malathion- and chlorpyrifos-induced immunotoxicity by modulating TLRx-NOX-ROS. Nutrients 2020; 12: 616.","DOI":"10.3390\/nu12030616"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Bamberger C, Rossmeier A, Lechner K, et al. A walnut-enriched diet affects gut microbiome in healthy caucasian subjects: a randomized, controlled trial. Nutrients 2018; 10: 244.","DOI":"10.3390\/nu10020244"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Shin PK, Zoh Y, Choi J, Kim MS, Kim Y, Choi SW. Walnut phenolic extracts reduce telomere length and telomerase activity in a colon cancer stem cell model. Nutr Res Pract 2019; 13: 58\u201363.","DOI":"10.4162\/nrp.2019.13.1.58"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Koh SJ, Choi YI, Kim Y, et al. Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice. Eur J Nutr 2019; 58: 1603\u20131613.","DOI":"10.1007\/s00394-018-1704-3"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Lee J, Kim YS, Lee J, et al. Walnut phenolic extract and its bioactive compounds suppress colon cancer cell growth by regulating colon cancer stemness. Nutrients 2016; 8: 439.","DOI":"10.3390\/nu8070439"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Chung J, Kim YS, Lee J, Lee JH, Choi SW, Kim Y. Compositional analysis of walnut lipid extracts and properties as an anti-cancer stem cell regulator via suppression of the self-renewal capacity. Food Sci Biotechnol 2016; 25: 623\u2013629.","DOI":"10.1007\/s10068-016-0087-6"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 An JM, Kim E, Lee HJ, Park MH, Son DJ, Hahm KB. <i>Dolichos lablab<\/i> L. extracts as pharmanutrient for stress-related mucosal disease in rat stomach. J Clin Biochem Nutr 2020; 67: 89\u2013101.","DOI":"10.3164\/jcbn.20-11"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Mukai R, Handa O, Suyama Y, Majima A, Naito Y. Effectiveness of including probiotics to <i>Helicobacter pylori<\/i> eradication therapies. J Clin Biochem Nutr 2020; 67: 102\u2013104.","DOI":"10.3164\/jcbn.20-37"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Handa O, Naito Y, Osawa M, et al. Nutirents and probiotics: current trends in their use to eradicate <i>Helicobacter pylori<\/i>. J Clin Biochem Nutr 2020; 67: 26\u201328.","DOI":"10.3164\/jcbn.20-51"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Horie R, Handa O, Ando T, et al. <i>Helicobacter pylori<\/i> eradication therapy outcome according to clarithromycin susceptibility testing in Japan. Helicobacter 2020; 25: e12698.","DOI":"10.1111\/hel.12698"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/68\/1\/68_20-103\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T20:59:57Z","timestamp":1723755597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/68\/1\/68_20-103\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.20-103","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}